Freeman Mason
Insider CIK 1745948 · SCPH Director · CINC EVP Clinical Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CINC CinCor Pharma, Inc. | D To issuer deriv | 2023-02-24 | 2023-02-27 | 120,380 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | D To issuer deriv | 2023-02-24 | 2023-02-27 | 30,178 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | D To issuer deriv | 2023-02-24 | 2023-02-27 | 145,296 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | D To issuer | 2023-02-24 | 2023-02-27 | 40,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 100 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 2,494 | — | $0 | 40,000 | SEC↗ |
| CINC CinCor Pharma, Inc. | A Award | 2023-01-26 | 2023-01-30 | 40,000 | — | $0 | 42,500 | SEC↗ |
| CINC CinCor Pharma, Inc. | S Sale | 2022-06-10 | 2023-02-27 | 6 | $15.21 | $91 | 2,494 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 2,500 | $16.00 | $40.0K | 2,500 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 100 | $16.00 | $1.6K | 100 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 6,124 | — | $0 | 6,124 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2019-06-18 | 2019-06-20 | 6,124 | — | $0 | 6,124 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2018-07-20 | 2018-07-24 | 12,248 | — | $0 | 12,248 | SEC↗ |